Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Evaxion Biotech Q2 2024 GAAP EPS $(0.12) Beats $(0.26) Estimate, Sales $154.000K Beat $52.000K Estimate

Author: Benzinga Newsdesk | August 14, 2024 07:04am

Posted In: EVAX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist